Regencell Bioscience Holdings Ltd SEC filings RGC
Regencell Bioscience Holdings Ltd has 85 filings in SEC EDGAR's recent list, going back to Nov 13, 2020. Its latest annual report, Form 20-F, was filed on Oct 7, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on May 22, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Oct 7, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | May 22, 2026 | May 22, 2026 |
| 424B5 | Prospectus supplement | May 19, 2026 | — |
| 6-K | Current report (foreign issuer) | May 19, 2026 | May 19, 2026 |
| 6-K | Current report (foreign issuer) | May 19, 2026 | May 19, 2026 |
| 6-K | Current report (foreign issuer) | May 8, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Apr 17, 2026 | Apr 17, 2026 |
| 6-K | Current report (foreign issuer) | Mar 30, 2026 | Mar 30, 2026 |
| 6-K | Current report (foreign issuer) | Mar 30, 2026 | Mar 30, 2026 |
| 424B5 | Prospectus supplement | Mar 30, 2026 | — |
| F-3ASR | Registration statement | Mar 30, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 13, 2026 | Feb 13, 2026 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jun 30, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jun 30, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jun 17, 2025 | Jun 17, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | Jun 2, 2025 |
| 6-K | Current report (foreign issuer) | Jan 15, 2025 | Jan 15, 2025 |
| 20-F | Annual report (foreign issuer) | Oct 25, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Jun 20, 2024 | Jun 20, 2024 |
| 6-K | Current report (foreign issuer) | Jan 2, 2024 | Jan 2, 2024 |
| 6-K | Current report (foreign issuer) | Dec 15, 2023 | Dec 15, 2023 |
| 20-F | Annual report (foreign issuer) | Oct 27, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jun 15, 2023 | Jun 15, 2023 |
| 6-K | Current report (foreign issuer) | Jun 5, 2023 | Jun 5, 2023 |
| 6-K | Current report (foreign issuer) | Mar 17, 2023 | Mar 17, 2023 |
| 6-K | Current report (foreign issuer) | Feb 28, 2023 | Feb 28, 2023 |
| 6-K | Current report (foreign issuer) | Jan 4, 2023 | Jan 4, 2023 |
| 6-K | Current report (foreign issuer) | Dec 22, 2022 | Dec 22, 2022 |
| 20-F | Annual report (foreign issuer) | Oct 31, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Sep 12, 2022 | Sep 12, 2022 |
| 6-K | Current report (foreign issuer) | Jun 2, 2022 | Jun 2, 2022 |
| 6-K | Current report (foreign issuer) | May 18, 2022 | May 18, 2022 |
| 6-K | Current report (foreign issuer) | May 16, 2022 | May 16, 2022 |
| 6-K | Current report (foreign issuer) | Apr 26, 2022 | Apr 26, 2022 |
| 6-K | Current report (foreign issuer) | Feb 16, 2022 | Feb 16, 2022 |
| 6-K | Current report (foreign issuer) | Dec 13, 2021 | Dec 13, 2021 |
| 6-K | Current report (foreign issuer) | Nov 17, 2021 | Nov 17, 2021 |
| 20-F | Annual report (foreign issuer) | Oct 29, 2021 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Sep 7, 2021 | Sep 7, 2021 |
| 6-K | Current report (foreign issuer) | Sep 1, 2021 | Sep 1, 2021 |
| 6-K | Current report (foreign issuer) | Aug 20, 2021 | Aug 19, 2021 |
| 6-K | Current report (foreign issuer) | Jul 20, 2021 | Jul 20, 2021 |
| 424B4 | Prospectus | Jul 20, 2021 | — |
| EFFECT | Filing | Jul 15, 2021 | — |
| CERT | Filing | Jul 15, 2021 | — |
| 8-A12B | For registration of certain classes | Jul 15, 2021 | — |
| CORRESP | Letter to the SEC | Jul 13, 2021 | — |
| CORRESP | Letter to the SEC | Jul 13, 2021 | — |
| FWP | Free writing prospectus | Jul 8, 2021 | — |
| FWP | Free writing prospectus | Jun 30, 2021 | — |
| F-1/A | Amendment no. 3 to form f-1 | Jun 23, 2021 | — |
| CORRESP | Letter to the SEC | Jun 22, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2021 | — |
| CORRESP | Letter to the SEC | Jun 11, 2021 | — |
| F-1/A | Amendment no. 2 to form f-1 | Jun 11, 2021 | — |
| UPLOAD | Letter from the SEC | May 3, 2021 | — |
| F-1/A | Amendment no. 1 to form f-1 | Apr 26, 2021 | — |
| CORRESP | Letter to the SEC | Apr 26, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Mar 22, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 18, 2021 | — |
| DRS/A | Filing | Feb 4, 2021 | — |
| DRSLTR | Filing | Feb 3, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 11, 2020 | — |
| DRS | Filing | Nov 13, 2020 | — |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- RGC (Nasdaq)
- Incorporated in
- Cayman Islands
- Headquarters
- Hong Kong
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1829667
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.